Programmable DNA drug destroying all cancers, unlocking 80% of targets
FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.
What they do:
Unleash the potential of genomic medicine using AI
Quick facts:
Funding:
€23.2M · Series B · Oct 2026
What they do:
Enabling next generation medicines. A comprehensive platform and…
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Developing milk-inspired therapeutics for infectious diseases
Quick facts:
HQ: Davis, CA, United States
What they do:
Empowering women. Period.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Curing and preventing type 1 diabetes
Quick facts:
HQ: San Francisco, CA, United States
What they do:
A research lab for one
Quick facts:
HQ: San Francisco, CA, United States
Programmable DNA drug destroying all cancers, unlocking 80% of targets
Oxford, United Kingdom
5 employees, according to the company profile.
There are no funding rounds for FinalDose in our data.
Similar startups: WhiteLab Genomics, 64x Bio, and Matrubials.